Published Research

Set and setting in psilocybin-assisted therapy

General Hospital Psychiatry

Can research, data, and technology aid the development of psychedelic medicine?

Journal of Psychopharmacology, Jan 2022.

The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder

Journal of Clinical Oncology, June 2022.

Psilocybin-assisted therapy improves psychosocial well-being in cancer patients

Journal of Affective Disorders, Dec 2022.

Psilocybin therapy for patients with cancer and major depression disorder

JAMA Oncology, April 2023.

Psilocybin‐assisted group therapy in patients diagnosed with cancer and depression

Cancer, July 2023.

Direct observation measure of therapeutic connection in psilocybin-assisted therapy

Journal of Palliative Medicine, August 2023.

Group psychedelic therapy: empirical estimates of cost-savings and improved access

Frontiers in Psychiatry, Dec. 2023.

Acceptability of psilocybin-assisted group therapy in patients with cancer and MDD

Cancer, Dec 2023.

The potential for psychedelics to treat Prolonged Grief Disorder

International Review of Psychiatry, May 2024.

Adverse events should not be surprising in psychedelic research

Psychedelic Medicine, September 2024.

The epidemiology of psychedelic use among U. S. military veterans

Journal of Psychoactive Drugs, Sep 2024.